Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of molecular tools designed to offer deoxyribonucleic acid engineering services. The company's Staby, is very flexible and used for synthetic biology, allowing successful cloning of genes and expression of recombinant proteins at a higher yield, enabling researchers to reach their goal faster and more efficiently.
You’re viewing a free company profile from the PitchBook Platform. To explore Delphi Genetics’s full profile, request a free trial.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Later Stage VC | 10-Mar-2015 | $1M | 000 | Completed | Startup |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
---|---|---|---|---|---|---|
Invest4 DelphiG2 | Other | Minority | 000 0000 | 000000 0 | ||
Michel Milinkovitch | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
SambrInvest | Venture Capital | Minority | 000 0000 | 000000 0 | ||
Université Libre de Bruxelles | Other | Minority | 000 0000 | 000000 0 | ||
Theodorus | Venture Capital | Minority | 000 0000 | 000000 0 |